Labetalol Hcl In Dextrose Injection
Product Images NDC 0143-9366

13 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Labetalol Hcl In Dextrose (NDC 0143-9366). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Labetalol HCl In Sodium Chloride And Dextrose Inje 1)

Figure 1 (Labetalol HCl In Sodium Chloride And Dextrose Inje 1)
An instructional line drawing of a 2 mL single dose syringe labeled with volume markings and the Hikma logo. Annotations identify the syringe tip cap (marked to remove), the external collar (marked do not remove), the label on the syringe barrel, and the plunger rod.*
FDA Label Image

Figure 2 (Labetalol HCl In Sodium Chloride And Dextrose Inje 2)

Figure 2 (Labetalol HCl In Sodium Chloride And Dextrose Inje 2)
An instructional illustration showing two hands opening or twisting a cap or seal from a vial or similar container, indicating the motion with a curved arrow.*
FDA Label Image

Structural Formula (Labetalol HCl In Sodium Chloride And Dextrose Inje 3)

Structural Formula (Labetalol HCl In Sodium Chloride And Dextrose Inje 3)
Chemical structure of labetalol hydrochloride showing the molecular arrangement of atoms and bonds including the aromatic rings, hydroxyl groups, amine, and hydrochloride component.*
FDA Label Image

Bag 9363 (Labetalol HCl In Sodium Chloride And Dextrose Inje 4)

Bag 9363 (Labetalol HCl In Sodium Chloride And Dextrose Inje 4)
Label for Labetalol Hydrochloride Injection in 0.72% Sodium Chloride, 100 mg per 100 mL (1 mg/mL) concentration. The product is indicated for intravenous infusion and comes in a ready-to-use, single-dose flexible container. Manufactured by Hikma Pharmaceuticals USA Inc., the label includes usage instructions, storage conditions, and preservative information.*
FDA Label Image

100 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 5)

100 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 5)
Label of Labetalol Hydrochloride in 0.72% Sodium Chloride Injection, 1 mg/mL strength, for intravenous infusion. It is a sterile, nonpyrogenic, single-dose flexible container with a 100 mL volume. Manufactured by HIKMA Farmacêutica and distributed by Hikma Pharmaceuticals USA Inc. The label includes usage instructions and storage conditions.*
FDA Label Image

Bag 9364 (Labetalol HCl In Sodium Chloride And Dextrose Inje 6)

Bag 9364 (Labetalol HCl In Sodium Chloride And Dextrose Inje 6)
Label for Labetalol Hydrochloride in 0.72% Sodium Chloride Injection, 200 mg per 200 mL (1 mg/mL) intravenous infusion. The label indicates a sterile, nonpyrogenic, single-dose flexible container. It is ready to use and preservative-free, manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

200 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 7)

200 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 7)
Labetalol Hydrochloride 1 mg/mL Injection in 0.72% Sodium Chloride, 200 mL single-dose flexible container for intravenous infusion. The label states it is sterile, nonpyrogenic, ready to use, and includes handling instructions and storage conditions. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Bag 9365 (Labetalol HCl In Sodium Chloride And Dextrose Inje 8)

Bag 9365 (Labetalol HCl In Sodium Chloride And Dextrose Inje 8)
Label for Labetalol Hydrochloride 1 mg/mL injection in 0.72% Sodium Chloride, available in a 300 mL flexible container with a total of 300 mg per container. The label indicates this is for intravenous infusion, sterile, nonpyrogenic, and preservative-free. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

300 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 9)

300 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 9)
Label for Labetalol Hydrochloride in 0.72% Sodium Chloride Injection, 300 mg per 300 mL (1 mg/mL), for intravenous infusion. The label states it is sterile, nonpyrogenic, in a single-dose flexible container, ready to use. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Bag 9366 (Labetalol HCl In Sodium Chloride And Dextrose Inje 10)

Bag 9366 (Labetalol HCl In Sodium Chloride And Dextrose Inje 10)
Label for Labetalol Hydrochloride injection in 5% Dextrose, 200 mg per 200 mL (1 mg/mL) intravenous solution. The label states it is sterile, nonpyrogenic, and ready to use in a single-dose flexible container. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc. Additional storage and usage instructions are included.*
FDA Label Image

200 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 11)

200 mg Overwrap (Labetalol HCl In Sodium Chloride And Dextrose Inje 11)
Label for Labetalol Hydrochloride in 5% Dextrose Injection, 200 mg per 200 mL (1 mg/mL) intravenous infusion. The label indicates a sterile, nonpyrogenic, single-dose flexible container, ready to use. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Labetalol 4 mL Vial Label (Labetalol HCl In Sodium Chloride And Dextrose Inje 12)

Labetalol 4 mL Vial Label (Labetalol HCl In Sodium Chloride And Dextrose Inje 12)
Label for Labetalol HCl Injection, USP 20 mg per 4 mL (5 mg/mL) solution for intravenous use only, single-dose vial containing 4 mL. The label includes storage instructions, inactive ingredients, and manufacturer information for Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Labetalol 4 mL Carton Label (Labetalol HCl In Sodium Chloride And Dextrose Inje 13)

Labetalol 4 mL Carton Label (Labetalol HCl In Sodium Chloride And Dextrose Inje 13)
Label for Labetalol HCl Injection, USP 20 mg per 4 mL (5 mg/mL) preservative-free intravenous injection solution. The product is supplied as 10 single-dose vials of 4 mL each, intended for intravenous use only. The label includes storage instructions, composition, and is manufactured by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.